Molybdenum-99 for Medical Imaging (2016) / Chapter Skim
Currently Skimming:
Appendix A: The American Medical Isotopes Production Act of 2012
Appendix A: The American Medical Isotopes Production Act of 2012
Pages 213-222
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 213... ...
SHORT TITLE. This subtitle may be cited as the "American Medical Isotopes Production Act of 2012".
|
From page 214... ...
(3) EXEMPTION. -- An existing reactor in the United States fueled with highly enriched uranium shall not be disqualified from the pro gram if the Secretary determines that -- (A)
|
From page 215... ...
to retain responsibility for the final disposition of spent nuclear fuel created by the irradiation, processing, or purification of uranium leased under this section for the pro duction of medical isotopes; and (ii) to take title to and be responsible for the final disposi tion of radioactive waste created by the irradiation, process ing, or purification of uranium leased under this section for which the Secretary determines the producer does not have access to a disposal path.
|
From page 216... ...
(5) AUTHORIZED USE OF FUNDS. -- Subject to the availabil ity of appropriations, the Secretary may obligate and expend funds received under leases entered into under this subsection, which shall remain available until expended, for the purpose of carrying out the activities authorized by this subtitle, including activities related to the final disposition of spent nuclear fuel and radioactive waste for which the Department is responsible under paragraph (3)
|
From page 217... ...
may be extended for no more than 6 years if, no earlier than 6 years after the date of enactment of the American Medical Isotopes Production Act of 2012, the Secretary of Energy certifies to the Committee on Energy and Commerce of the House of Representatives and the Committee on Energy and Natural Resources of the Senate that -- "(1) there is insufficient global supply of molybdenum-99 produced without the use of highly enriched uranium available to satisfy the domestic United States market; and "(2)
|
From page 218... ...
REPORT ON DISPOSITION OF EXPORTS. Not later than 1 year after the date of the enactment of this Act, the Chairman of the Nuclear Regulatory Commission, after consulting with other relevant agencies, shall submit to the Congress a report detailing the current disposition of previous United States exports of highly enriched uranium used as fuel or targets in a nuclear research or test reactor, including -- (1)
|
From page 219... ...
the proposed recipient of the medical isotope pro duction target has provided assurances that, whenever an alternative medical isotope production target can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and "(2) the Secretary of Energy has certified that the United States Government is actively supporting the development of an alterna tive medical isotope production target that can be used in that reactor.
|
From page 220... ...
(a) In general. -- Not later than 1 year after the date of enactment of this Act, and annually thereafter for 5 years, the Secretary shall report to Congress on Department actions to support the production in the United States, without the use of highly enriched uranium, of molybdenum-99 for medical uses.
|
From page 221... ...
(2) An assessment of the progress made by the Department and others to eliminate all worldwide use of highly enriched uranium in reactor fuel, reactor targets, and medical isotope production facilities.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.